OrbiMed’s Oak Street Health, Inc. OSH Stock Holding History

OrbiMed’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,290,300	Closed	-$42.8M	–	170
2021 Q4	$42.8M	Sell	1,290,300 -38,000	-3%	-$1.44M	0.55%	53
2021 Q3	$56.5M	Hold	1,328,300	–	–	0.62%	49
2021 Q2	$77.8M	Buy	1,328,300 +361,300	+37%	+$21.5M	0.79%	42
2021 Q1	$52.5M	Buy	967,000 +518,900	+116%	+$28.9M	0.49%	56
2020 Q4	$27.4M	Buy	448,100 +113,700	+34%	+$5.97M	0.24%	86
2020 Q3	$17.9M	Buy	+334,400	New	+$15M	0.22%	87

Other funds holding OSH

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

OrbiMed's OSH Position: Q1 2022 in Review

OrbiMed sold out of Oak Street Health, Inc. (OSH) in Q1 2022, closing a stake of 1,290,300 shares — an estimated $42.8M sold.

OrbiMed first reported a position in OSH in Q3 2020 and held it in 6 quarters. The position peaked at $77.8M in Q2 2021. 209 funds tracked by Wall St. Rank hold OSH as of Q1 2022.

OrbiMed reported no remaining Oak Street Health, Inc. position as of Q1 2022 after selling out during the quarter.
OrbiMed sold 1,290,300 Oak Street Health, Inc. shares in Q1 2022, an estimated $42.8M.
OrbiMed first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 6 quarters.
OrbiMed's Oak Street Health, Inc. position peaked at $77.8M in Q2 2021.
209 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q1 2022.

Based on OrbiMed's 13F filing for Q1 2022, filed 16 May 2022.